Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

IO-CTNG: A Multi-Centre Evaluation of the Atlas Genetics io® CTNG System Used in Centralised and Point of Care Settings

NCT03071510 is registered in ClinicalTrials.gov with Binx Health Limited as lead sponsor.

NCT NCT03071510
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03071510 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
IO-CTNG: A Multi-Centre Evaluation of the Atlas Genetics io® CTNG System Used in Centralised and Point of Care Settings
Lead sponsor
Binx Health Limited
Phase
Observational
Overall status
Completed
Start date
May 18, 2017
Completion date
August 30, 2019
Enrollment
7,128 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

chlamydia trachomatis, gonorrhea